Home/Filings/4/0001181431-14-004597
4//SEC Filing

AtriCure, Inc. 4

Accession 0001181431-14-004597

$ATRCCIK 0001323885operating

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:42 PM ET

Size

36.8 KB

Accession

0001181431-14-004597

Insider Transaction Report

Form 4
Period: 2014-01-30
Transactions
  • Exercise/Conversion

    Common Stock

    2014-01-30$12.00/sh+10,000$120,00010,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$9.37/sh+30,000$281,10040,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$5.15/sh+10,000$51,50090,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$8.04/sh+3,334$26,805100,001 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$7.99/sh+10,000$79,90050,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$9.50/sh+10,000$95,00060,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$10.10/sh+10,000$101,00070,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$2.58/sh+10,000$25,80080,000 total
  • Exercise/Conversion

    Common Stock

    2014-01-30$14.17/sh+6,667$94,47196,667 total
  • Other

    Common Stock

    2014-01-30100,0010 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $12.00From: 2006-08-05Exp: 2015-08-05Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3030,0000 total
    Exercise: $9.37From: 2007-04-06Exp: 2016-04-06Common Stock (30,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $7.99From: 2007-06-21Exp: 2016-06-21Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $9.50From: 2008-06-20Exp: 2017-06-20Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $10.10From: 2009-05-28Exp: 2018-05-28Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $2.58From: 2010-05-21Exp: 2019-05-21Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-3010,0000 total
    Exercise: $5.15From: 2011-05-19Exp: 2020-05-19Common Stock (10,000 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-306,6673,333 total
    Exercise: $14.17From: 2012-05-18Exp: 2021-05-18Common Stock (6,667 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2014-01-303,3346,666 total
    Exercise: $8.04From: 2013-05-15Exp: 2022-05-15Common Stock (3,334 underlying)
Footnotes (10)
  • [F1]Shares transferred to Camden Partners Holdings, LLC.
  • [F10]These options were granted on May 15, 2012 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F2]These options were granted on August 5, 2005 and are exercisable cumulatively at a rate of 25% per annum beginning one year from the date of grant.
  • [F3]These options were granted on April 6, 2006 and are exercisable cumulatively at a rate of 25% per annum beginning one year from the date of grant.
  • [F4]These options were granted on June 21, 2006 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F5]These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F6]These options were granted on May 28, 2008 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F7]These options were granted on May 21, 2009 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F8]These options were granted on May 19, 2010 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.
  • [F9]These options were granted on May 18, 2011 and are exercisable cumulatively at a rate of 33% per annum beginning one year from the date of grant.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001323885

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 4:42 PM ET
Size
36.8 KB